Class Action News

Brower Piven Announces Class Action Lawsuit Against Rambus

BALTIMORE, MD --The law firm of Brower Piven, A Professional Association, today announced that a securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Rambus Inc. (NASDAQ: RMBS) between January 14, 2004 and July 18, 2006, inclusive (the "Class Period").

The case is pending in the United States District Court for the Northern District of California against defendant Rambus and one or more of its officers and/or directors. The action charges that defendants violated federal securities laws by issuing a series of materially false and misleading statements to the market throughout the Class Period, which statements had the effect of artificially inflating the market price of the Company's securities.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you are a member of the proposed class, you may move the court no later than September 18, 2006 to serve as a lead plaintiff for the proposed class. In order to serve as a lead plaintiff, you must meet certain legal requirements. To be a member of the proposed class you need not take any action at this time, and you may retain counsel of your choice.

If you acquired shares of Rambus Inc. during the Class Period indicated and want to discuss your legal rights, you may e-mail or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions.

Contact our Texas Class Action Lawyer Now!

	Did You Know?
	Vioxx is one of the recalled drugs that has caused a major class action lawsuit. The class action lawsuit against Merck will include individuals in the United States who used Vioxx between May 20, 1999 and September 30, 2004 for at least six consecutive weeks. Currently, Merck is facing more than 27,000 Vioxx lawsuits, which the company plans to litigate individually.